COLLECTIONS
WORKFLOWS
Recent Finacing
Recent Raise
Aelin Therapeutics develops Pept‑in™, a proprietary protein‑aggregation platform that induces intracellular functional knockdown to create therapeutics against previously undruggable targets across bacteria, fungi, viruses, cancer, and plants.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors